Knockout Tested Rabbit Recombinant Monoclonal PLCG 2 antibody. Carrier free. Suitable for IP, IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
IP | IHC-P | ICC/IF | WB | Flow Cyt (Intra) | |
---|---|---|---|---|---|
Human | Tested | Tested | Not recommended | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. It is a crucial enzyme in transmembrane signaling.
Phosphoinositide phospholipase C-gamma-2, Phospholipase C-IV, Phospholipase C-gamma-2, PLC-IV, PLC-gamma-2, PLCG2
Knockout Tested Rabbit Recombinant Monoclonal PLCG 2 antibody. Carrier free. Suitable for IP, IHC-P, WB, Flow Cyt (Intra) and reacts with Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab248535 is the carrier-free version of Anti-PLCG 2 antibody [EPR5914-34] ab133522.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-PLCG 2 antibody [EPR5914-34] ab133522, the same antibody clone in a different buffer formulation.Immunohistochemistry analysis of Paraffin Embedded Human gastric adenocarcinoma tissue labelling PLCG2 with Anti-PLCG 2 antibody [EPR5914-34] ab133522 at 1/100 dilution. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
This data was developed using Anti-PLCG 2 antibody [EPR5914-34] ab133522, the same antibody clone in a different buffer formulation.
All lanes: Western blot - Anti-PLCG 2 antibody [EPR5914-34] - BSA and Azide free (ab248535) at 1/10000 dilution
Lane 1: Raji cell lysates at 10 µg
Lane 2: Ramos cell lysates at 10 µg
All lanes: HRP-labelled Goat anti-Rabbit at 1/2000 dilution
Predicted band size: 148 kDa
This data was developed using Anti-PLCG 2 antibody [EPR5914-34] ab133522, the same antibody clone in a different buffer formulation.
Flow Cytometry analysis of Human Peripheral Blood Mononuclear Cell (PBMC) cells labeling PLCG 2 with purified Anti-PLCG 2 antibody [EPR5914-34] ab133522 at 1/1000 dilution (1 μg/mL) (Red). Cells were fixed with 2% Paraformaldehyde and permeabilised with 0.1% Tween-20. A Goat anti rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Left).
Cells were surface stained with anti-CD19 conjugated to PE/Cy7, then fixed with 2% PFA followed by intracellularly stained with rabbit IgG or Anti-PLCG 2 antibody [EPR5914-34] ab133522. Gated on lymphocytes.
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody.
Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
This data was developed using Anti-PLCG 2 antibody [EPR5914-34] ab133522, the same antibody clone in a different buffer formulation.
Anti-PLCG2 antibody [EPR5914-34] (Anti-PLCG 2 antibody [EPR5914-34] ab133522) staining at 1/10000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (Anti-Calnexin antibody [CANX/1543] ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, Anti-PLCG 2 antibody [EPR5914-34] ab133522 was shown to bind specifically to PLCG2. A band was observed at 148 kDa in wild-type HAP1 cell lysates with no signal observed at this size in PLCG2 knockout cell line. To generate this image, wild-type and PLCG2 knockout HAP1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes: Western blot - Anti-PLCG 2 antibody [EPR5914-34] (Anti-PLCG 2 antibody [EPR5914-34] ab133522) at 1/10000 dilution
All lanes: Western blot at 20 µg
All lanes: Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Performed under reducing conditions.
Predicted band size: 148 kDa
Observed band size: 148 kDa
This data was developed using Anti-PLCG 2 antibody [EPR5914-34] ab133522, the same antibody clone in a different buffer formulation.
Western blot: Anti-PLCG2 antibody [EPR5914-34] (Anti-PLCG 2 antibody [EPR5914-34] ab133522) staining at 1/10000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, Anti-PLCG 2 antibody [EPR5914-34] ab133522 was shown to bind specifically to PLCG2. A band was observed at 150 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in PLCG2 knockout cell line. To generate this image, wild-type and PLCG2 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes: Western blot - Anti-PLCG 2 antibody [EPR5914-34] (Anti-PLCG 2 antibody [EPR5914-34] ab133522) at 1/10000 dilution
Lane 1: Wild-type HCT 116 cell lysate at 20 µg
Lane 2: Western blot - Human PLCG2 knockout HCT116 cell line (Human PLCG2 knockout HCT116 cell line ab301166)
Lane 2: PLCG2 knockout HCT 116 cell lysate at 20 µg
Lanes 1 - 2: Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution
Lanes 1 - 2: Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Performed under reducing conditions.
Observed band size: 150 kDa
Western blot: antibody description (ab248535) staining at 10,000 dilution, shown in Black. In Western blot, ab248535 was shown to bind specifically to PLCG2. An enriched band was observed at 160 kDa in samples pulled down with ab248535 with no band observed in Isotype control sample. Following IP, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween$®$ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with a high-sensitivity ECL substrate kit and imaged. Secondary antibodies used was VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution.
Lanes 1 - 2: Immunoprecipitation - Anti-PLCG 2 antibody [EPR5914-34] - BSA and Azide free (ab248535) at 1/10000 dilution
Lanes 1 - 2: Immunoprecipitation - Anti-PLCG 2 antibody [EPR5914-34] (Anti-PLCG 2 antibody [EPR5914-34] ab133522)
Lane 1: HAP1 Input cell lysate at 10 µg
Lane 2: HAP1 pulldown with ab248535 at 10 µg
Lane 3: HAP1 pulldown with Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730 Isotype control at 10 µg
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) at 1/1000 dilution
Developed using the ECL technique.
Observed band size: 160 kDa
Exposure time: 4min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com